Nirogacestat
Nirogacestat is a small molecule gamma secretase inhibitor that is under investigation for the treatment of various types of cancer, most notably multiple myeloma and desmoid tumors. Gamma secretase is an enzyme complex that plays a crucial role in the activation of the Notch signaling pathway, which is implicated in the regulation of cell differentiation, proliferation, and apoptosis. Dysregulation of the Notch pathway has been associated with the pathogenesis of several types of cancer, making gamma secretase a target for cancer therapy.
Mechanism of Action
Nirogacestat functions by inhibiting the gamma secretase complex, thereby preventing the proteolytic cleavage of Notch receptors. This inhibition leads to the suppression of the Notch signaling pathway, which can halt the proliferation of cancer cells and induce apoptosis. By targeting the Notch pathway, nirogacestat has the potential to interfere with the communication signals that cancer cells use to grow and survive.
Clinical Trials
As of the current knowledge cutoff in 2023, nirogacestat has been evaluated in various stages of clinical trials for its efficacy and safety in treating multiple myeloma, desmoid tumors, and other Notch pathway-related cancers. In desmoid tumors, which are rare and often aggressive fibrous neoplasms, nirogacestat has shown promise in reducing tumor size and preventing progression. For multiple myeloma, research is ongoing to determine its effectiveness, both as a monotherapy and in combination with other therapeutic agents.
Pharmacokinetics
The pharmacokinetic profile of nirogacestat involves its absorption, distribution, metabolism, and excretion characteristics in the human body. Details on its half-life, bioavailability, and routes of elimination are crucial for optimizing its dosage and administration schedule to maximize therapeutic efficacy while minimizing potential side effects.
Adverse Effects
Like all therapeutic agents, nirogacestat is associated with a range of potential adverse effects. Commonly reported side effects include gastrointestinal disturbances, fatigue, and skin-related issues. Severe adverse effects are rare but may include increased risk of infections due to immunosuppression. Ongoing clinical trials aim to further elucidate the safety profile of nirogacestat.
Future Directions
Research on nirogacestat continues to explore its potential applications in oncology, with a focus on expanding its use to other Notch pathway-related cancers. Additionally, studies are investigating the possibility of combining nirogacestat with other cancer therapies to enhance its efficacy and overcome resistance mechanisms.
| Chemotherapy | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This Chemotherapy related article is a stub.
|
Resources
| Additional resources | ||
|---|---|---|
|
Nirogacestat
|
<html><link rel="canonical" href="https://wikimd.com/wiki/Nirogacestat">
<meta name=”viewport” content=”width=device-width, initial-scale=1″>
</html>
Ad. Transform your life with W8MD's Budget GLP-1 injections from $49.99
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $49.99 for the starting dose of Semaglutide and $65.00 for Tirzepatide.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
